Table of Contents
ISRN Urology
Volume 2011, Article ID 458930, 6 pages
http://dx.doi.org/10.5402/2011/458930
Research Article

Downstaging of TURBT-Based Muscle-Invasive Bladder Cancer by Radical Cystectomy Predicts Better Survival

1Department of Urology, Radboud University Nijmegen Medical Centre, 6500 HB Nijmegen, The Netherlands
2Department of Epidemiology, Biostatistics, and HTA, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
3Department of Cancer Registry and Research, Comprehensive Cancer Centre East, P.O. Box 1281, 6501 BG Nijmegen, The Netherlands
4Department of Urology, Rijnstate Hospital, P.O. Box 9555, 6815 AD Arnhem, The Netherlands
5Department of Urology, Canisius Wilhelmina Hospital, P.O. Box 9015, 6500 GS Nijmegen, The Netherlands
6Department of Urology, St. Jansdal Hospital, P.O. Box 138, 3840 AC Harderwijk, The Netherlands
7Department of Urology, Hospital Gelderse Vallei, P.O. Box 9025, 6710 HN Ede, The Netherlands
8Department of Urology, Slingeland Hospital, P.O. Box 169, 7000 AD Doetinchem, The Netherlands
9Department of Urology, Maas Hospital, P.O. Box 55, 5830 AB Boxmeer, The Netherlands

Received 24 February 2011; Accepted 18 March 2011

Academic Editors: R. B. Moore, A. Natali, and T. Okamura

Copyright © 2011 P. R. van Dijk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. K. Hollenbeck, D. C. Miller, R. L. Dunn, J. E. Montie, and J. T. Wei, “The effects of stage divergence on survival after radical cystectomy for urothelial cancer,” Urologic Oncology: Seminars and Original Investigations, vol. 23, no. 2, pp. 77–81, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. H. W. Herr, “The value of a second transurethral resection in evaluating patients with bladder tumors,” Journal of Urology, vol. 162, no. 1, pp. 74–76, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. S. S. Chang, J. M. Hassan, M. S. Cookson, N. Wells, and J. A. Smith, “Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage,” Journal of Urology, vol. 170, no. 4 I, pp. 1085–1087, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Pagano, P. Bassi, T. P. Galetti et al., “Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification,” Journal of Urology, vol. 145, no. 1, pp. 45–50, 1991. View at Google Scholar · View at Scopus
  5. S. F. Shariat, G. S. Palapattu, P. I. Karakiewicz et al., “Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy,” European Urology, vol. 51, no. 1, pp. 137–151, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Isbarn, P. I. Karakiewicz, S. F. Shariat et al., “Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer,” Journal of Urology, vol. 182, no. 2, pp. 459–465, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. E. Nielsen, P. J. Bastian, G. S. Palapattu et al., “Recurrence-free survival after radical cystectomy of patients downstaged by transurethral resection,” Urology, vol. 70, no. 6, pp. 1091–1095, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. B. G. Volkmer, R. Kuefer, G. Bartsch et al., “Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival,” Cancer, vol. 104, no. 11, pp. 2384–2391, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. G. S. Palapattu, S. F. Shariat, P. I. Karakiewicz et al., “Cancer specific outcomes in patients with pT0 disease following radical cystectomy,” Journal of Urology, vol. 175, no. 5, pp. 1645–1649, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Loizaga Iriarte, N. Senarriaga Ruiz de la Illa, I. Lacasa Viscasillas, A. Rábade Ferreiro, I. Iriarte Soldevilla, and M. Unda Urzaiz, “Does a pT0 cystectomy specimen imply being tumour-free in the long term?” Actas Urologicas Espanolas, vol. 33, no. 8, pp. 865–868, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. B. Thrasher, H. A. Frazier, J. E. Robertson, and D. F. Paulson, “Does a stage pT0 cystectomy specimen confer a survival advantage in patients with minimally invasive bladder cancer?” Journal of Urology, vol. 152, no. 2, pp. 393–396, 1994. View at Google Scholar · View at Scopus
  12. International Union against Cancer (IUCC), TNM Classification of Malignant Tumors, 5th edition, 2009.
  13. P. W. Dickman, A. Sloggett, M. Hills, and T. Hakulinen, “Regression models for relative survival,” Statistics in Medicine, vol. 23, no. 1, pp. 51–64, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. H. W. Herr, “Transurethral resection of muscle-invasive bladder cancer: 10-year outcome,” Journal of Clinical Oncology, vol. 19, no. 1, pp. 89–93, 2001. View at Google Scholar · View at Scopus
  15. A. Stenzl, N. C. Cowan, M. De Santis et al., “Guidelines on bladder cancer: muscle invasive and metastatic,” Uropean Association of Urology, 2008.